Boston Partners lessened its position in shares of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) by 0.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,870,243 shares of the software maker’s stock after selling 14,348 shares during the quarter. Boston Partners owned 1.04% of Allscripts Healthcare Solutions worth $27,212,000 at the end of the most recent reporting period.
Other institutional investors have also recently bought and sold shares of the company. Archford Capital Strategies LLC grew its stake in Allscripts Healthcare Solutions by 6,124.0% during the 2nd quarter. Archford Capital Strategies LLC now owns 6,224 shares of the software maker’s stock valued at $958,000 after purchasing an additional 6,124 shares during the last quarter. Sheaff Brock Investment Advisors LLC purchased a new stake in Allscripts Healthcare Solutions during the 3rd quarter valued at about $174,000. Quantitative Systematic Strategies LLC purchased a new stake in Allscripts Healthcare Solutions during the 4th quarter valued at about $182,000. Crossmark Global Holdings Inc. purchased a new stake in Allscripts Healthcare Solutions during the 3rd quarter valued at about $187,000. Finally, Shelton Capital Management acquired a new position in shares of Allscripts Healthcare Solutions in the 2nd quarter valued at about $170,000.
Several brokerages have recently issued reports on MDRX. Zacks Investment Research raised Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a report on Thursday, January 25th. Citigroup began coverage on Allscripts Healthcare Solutions in a report on Thursday, January 4th. They issued a “buy” rating for the company. SunTrust Banks cut Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a report on Tuesday, January 16th. They noted that the move was a valuation call. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $17.00 price target on shares of Allscripts Healthcare Solutions in a report on Sunday, January 28th. Finally, KeyCorp reaffirmed a “hold” rating on shares of Allscripts Healthcare Solutions in a report on Friday, October 27th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and eleven have assigned a buy rating to the company. Allscripts Healthcare Solutions currently has a consensus rating of “Buy” and a consensus target price of $15.66.
Shares of Allscripts Healthcare Solutions Inc (NASDAQ MDRX) opened at $14.45 on Thursday. The company has a debt-to-equity ratio of 1.20, a current ratio of 0.98 and a quick ratio of 0.98. The stock has a market capitalization of $2,558.44, a P/E ratio of 32.93, a PEG ratio of 2.00 and a beta of 1.18. Allscripts Healthcare Solutions Inc has a 52-week low of $11.25 and a 52-week high of $16.13.
Allscripts Healthcare Solutions Profile
Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.
Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.